165 related articles for article (PubMed ID: 37142535)
21. [Bladder-sparing trimodal therapy for muscle invasive bladder cancer].
Khalifa J; Roumiguié M; Pouessel D; Sargos P
Cancer Radiother; 2022 Oct; 26(6-7):771-778. PubMed ID: 35970682
[TBL] [Abstract][Full Text] [Related]
22. Female Sexual Function Following Radical Cystectomy in Bladder Cancer.
Davis L; Isali I; Prunty M; Calaway A; Mishra K; Miller A; Pope R; Magee D; Bigalli AC; Thirumavalavan N; Ponsky L; Bukavina L
Sex Med Rev; 2022 Apr; 10(2):231-239. PubMed ID: 34992003
[TBL] [Abstract][Full Text] [Related]
23. Can bladder preservation therapy come to the center stage?
Inamoto T; Ibuki N; Komura K; Juri H; Yamamoto K; Yamamoto K; Fujita K; Nonomura N; Narumi Y; Azuma H
Int J Urol; 2018 Feb; 25(2):134-140. PubMed ID: 29171098
[TBL] [Abstract][Full Text] [Related]
24. Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients.
Kijima T; Tanaka H; Koga F; Masuda H; Yoshida S; Yokoyama M; Ishioka J; Matsuoka Y; Saito K; Kihara K; Fujii Y
BJU Int; 2019 Aug; 124(2):242-250. PubMed ID: 30811784
[TBL] [Abstract][Full Text] [Related]
25. Bladder-sparing treatment of invasive bladder cancer.
Rivera I; Wajsman Z
Cancer Control; 2000; 7(4):340-6. PubMed ID: 10895128
[TBL] [Abstract][Full Text] [Related]
26. Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials.
Arcangeli G; Strigari L; Arcangeli S
Crit Rev Oncol Hematol; 2015 Sep; 95(3):387-96. PubMed ID: 25934521
[TBL] [Abstract][Full Text] [Related]
27. Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries?
Taylor BL; Matrai CE; Smith AL; Ayangbesan A; Xia L; Golombos DM; Mosquera JM; Nicolas J; Robinson BD; Scherr DS; Khani F
Clin Genitourin Cancer; 2019 Feb; 17(1):e209-e215. PubMed ID: 30470630
[TBL] [Abstract][Full Text] [Related]
28. Female reproductive organ-sparing radical cystectomy: contemporary indications, techniques and outcomes.
Niver BE; Daneshmand S; Satkunasivam R
Curr Opin Urol; 2015 Mar; 25(2):105-10. PubMed ID: 25581538
[TBL] [Abstract][Full Text] [Related]
29. Organ-sparing procedures in GU cancer: part 3-organ-sparing procedures in urothelial cancer of upper tract, bladder and urethra.
Khalil MI; Alliston JT; Bauer-Erickson JJ; Davis R; Bissada NK; Kamel MH
Int Urol Nephrol; 2019 Nov; 51(11):1903-1911. PubMed ID: 31352580
[TBL] [Abstract][Full Text] [Related]
30. Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.
Mak KS; Smith AB; Eidelman A; Clayman R; Niemierko A; Cheng JS; Matthews J; Drumm MR; Nielsen ME; Feldman AS; Lee RJ; Zietman AL; Chen RC; Shipley WU; Milowsky MI; Efstathiou JA
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1028-1036. PubMed ID: 27727064
[TBL] [Abstract][Full Text] [Related]
31. Radical cystectomy with preservation of sexual function and fertility in patients with transitional cell carcinoma of the bladder: new technique.
Salem HK
Int J Urol; 2007 Apr; 14(4):294-8; discussion 299. PubMed ID: 17470156
[TBL] [Abstract][Full Text] [Related]
32. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.
Koga F; Kihara K; Yoshida S; Yokoyama M; Saito K; Masuda H; Fujii Y; Kawakami S
BJU Int; 2012 Mar; 109(6):860-6. PubMed ID: 21854531
[TBL] [Abstract][Full Text] [Related]
33. Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients.
Colombo R; Pellucchi F; Moschini M; Gallina A; Bertini R; Salonia A; Rigatti P; Montorsi F
World J Urol; 2015 Oct; 33(10):1389-95. PubMed ID: 25577131
[TBL] [Abstract][Full Text] [Related]
34. Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long term oncological, functional and quality of life results.
Stenzl A; Sherif H; Kuczyk M
Int Braz J Urol; 2010; 36(5):537-47. PubMed ID: 21044370
[TBL] [Abstract][Full Text] [Related]
35. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
Cahn DB; Handorf EA; Ghiraldi EM; Ristau BT; Geynisman DM; Churilla TM; Horwitz EM; Sobczak ML; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2017 Nov; 123(22):4337-4345. PubMed ID: 28743162
[TBL] [Abstract][Full Text] [Related]
36. Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis.
Schuettfort VM; Pradere B; Quhal F; Mostafaei H; Laukhtina E; Mori K; Sari Motlagh R; Fisch M; D'Andrea D; Rink M; Gontero P; Soria F; Shariat SF
World J Urol; 2021 Jun; 39(6):1757-1768. PubMed ID: 32995918
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation.
Zhong J; Switchenko J; Jegadeesh NK; Cassidy RJ; Gillespie TW; Master V; Nieh P; Alemozaffar M; Kucuk O; Carthon B; Filson CP; Bilen MA; Jani AB
Am J Clin Oncol; 2019 Jan; 42(1):36-41. PubMed ID: 29912804
[TBL] [Abstract][Full Text] [Related]
38. Influence of Simple and Radical Cystectomy on Sexual Function and Pelvic Organ Prolapse in Female Patients: A Scoping Review of the Literature.
Voigt M; Hemal K; Matthews C
Sex Med Rev; 2019 Jul; 7(3):408-415. PubMed ID: 31029621
[TBL] [Abstract][Full Text] [Related]
39. Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer.
Colombo R; Bertini R; Salonia A; Naspro R; Ghezzi M; Mazzoccoli B; Deho' F; Montorsi F; Rigatti P
J Urol; 2004 May; 171(5):1819-22; discussion 1822. PubMed ID: 15076284
[TBL] [Abstract][Full Text] [Related]
40. [Transitional cell carcinoma of the bladder: bladder-sparing therapy].
Vom Dorp F; Tschirdewahn S; Szarvas T; Rübben H; Kraemer R; Rehme C
Urologe A; 2014 Sep; 53(9):1322-8. PubMed ID: 25148911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
